NESIRITIDE: 26 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
26
Total FAERS Reports
4 (15.4%)
Deaths Reported
8
Hospitalizations
26
As Primary/Secondary Suspect
Aug 10, 2001
FDA Approved
Discontinued
Status
FDA Application: 020920 ·
First Report: 20040930 · Latest Report: 20241005
What Are the Most Common NESIRITIDE Side Effects?
#1 Most Reported
Hypotension
8 reports (30.8%)
#2 Most Reported
Acute kidney injury
5 reports (19.2%)
#3 Most Reported
Drug ineffective
3 reports (11.5%)
All NESIRITIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypotension | 8 | 30.8% | 1 | 2 |
| Acute kidney injury | 5 | 19.2% | 2 | 1 |
Who Reports NESIRITIDE Side Effects? Age & Gender Data
Gender: 44.4% female, 55.6% male. Average age: 65.1 years. Most reports from: US. View detailed demographics →
Is NESIRITIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 3 | 1 | 2 |
| 2005 | 3 | 1 | 2 |
| 2008 | 2 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 0 |
What Is NESIRITIDE Used For?
| Indication | Reports |
|---|---|
| Cardiac failure | 5 |
| Cardiac failure acute | 5 |
| Product used for unknown indication | 5 |
Official FDA Label for NESIRITIDE
Official prescribing information from the FDA-approved drug label.